Stockreport

Annovis Bio: Searching For Efficacy In Alzheimer's Disease [Seeking Alpha]

Annovis Bio, Inc.  (ANVS) 
PDF Of the five pre-specified efficacy endpoints, only ADAS-Cog11 results were reported in some details, and only from ~28% of the completed patients. I take a close look [Read more]